Form 8-K - Current report:
SEC Accession No. 0001193125-25-005654
Filing Date
2025-01-14
Accepted
2025-01-14 07:05:46
Documents
13
Period of Report
2025-01-10
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K d902412d8k.htm   iXBRL 8-K 25377
  Complete submission text file 0001193125-25-005654.txt   152050

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA calc-20250110.xsd EX-101.SCH 2878
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE calc-20250110_lab.xml EX-101.LAB 18738
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE calc-20250110_pre.xml EX-101.PRE 11726
16 EXTRACTED XBRL INSTANCE DOCUMENT d902412d8k_htm.xml XML 3806
Mailing Address 505 COAST BOULEVARD SOUTH SUITE 307 LA JOLLA CA 92037
Business Address 505 COAST BOULEVARD SOUTH SUITE 307 LA JOLLA CA 92037 858-952-5500
CalciMedica, Inc. (Filer) CIK: 0001534133 (see all company filings)

EIN.: 452120079 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39538 | Film No.: 25527744
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)